Hal E. Broxmeyer Explained

Hal E. Broxmeyer (1943/1944 – 8 December 2021) was an American microbiologist. He was a professor at the Mary Margaret Walther Program for Cancer Care Research, and Professor of Microbiology and Immunology at the Indiana University School of Medicine. He received a BS degree from Brooklyn College in 1969 and a PhD from New York University in 1973.^[1]

Life and career

Broxmeyer was internationally recognized for his work on human umbilical cord blood as a source of transplantable hematopoietic stem cells.^[2] In 1988, he first coordinated a study in successfully demonstrating clinical utility of cord blood transplantation to cure a hematological disorder of a child (Fanconi anemia) working together with Dra. Gluckman. This intervention took place in Hospital Saint-Louis (Paris) and was successful. ^[3] Work from his laboratory established the field of clinical cord blood transplantation.

He died from thyroid cancer on 8 December 2021, at the age of 77.^[4]

Awards and honors

1. Dirk van Bekkum Award (2002)
2. E. Donnall Thomas Prize and Lecture (2006)^[5]
3. President, American Society of Hematology (2010)^[6]
4. Elected Fellow of American Association for Advancement of Science (2012)^[7]

Notes and References

1. Web site: Hal E. Broxmeyer, PhD. 9 July 2020. medicine.iu.edu.
2. Proc National Academy Science USA. 1989 May; 86(10): pages 3828-32
3. New England Journal of Medicine 1989 October 26; 321(17): pages 1174-8
4. https://cancerletter.com/obituary/20211217_3/ Indiana University’s Hal Broxmeyer, pioneer of cord blood transplantation, dies at 77
5. Web site: E Donnall Thomas Lecture and Prize. 31 January 2018. Hematology.org. 8 April 2018.
6. Web site: Hal E. Broxmeyer, PhD. 30 March 2016. Hematology.org. 8 April 2018.
7. AAAS News and Notes. American Association for the Advancement of. Science. 30 November 2012. Science. 338. 6111. 1166–1171. 10.1126/science.338.6111.1166. free.